Guidance

Subcategories:Clinical Criteria/Guidelines Ethics Legal Updates Legislation & Advocacy Meeting Reports Research Rheum

Legal Updates: As Opioids for Pain Treatment Come Under Greater Scrutiny, Controlled Substance Agreements Matter More

Steven M. Harris, Esq. | March 1, 2013

These contracts can communicate a physician’s expectations for a pain treatment plan and guidelines for safe use by their patients

The ARHP Honors Health Professionals for their Contributions to Rheumatology

Richard Quinn | February 1, 2013

The ARHP recognized individuals for their work in advancing rheumatology research, education, and patient care at the organizations’ annual meeting in Washington, D.C. last November

With a Five-Point Plan and New Name, the Rheumatology Research Foundation Continues to Advance the Field of Rheumatology

Audrey B. Uknis, MD and David I. Daikh, MD, PhD | February 1, 2013

Supporting research and education in rheumatology is the core mission of the American College of Rheumatology’s (ACR) Rheumatology Research Foundation

ACR Leaders Converge on Capitol Hill

Staff | February 1, 2013

American College of Rheumatology (ACR) members to discuss legislation and regulatory issues facing rheumatologists at this year’s annual ACR Advocacy Leadership Conference in Washington, D.C.

A Rheumatology Research Foundation-funded Physician Studies the Overall Impact of Osteoarthritis

Staff | February 1, 2013

Amanda E. Nelson, MD, MSCR, is using a grant from the Rheumatology Research Foundation to create a way to measure of the overall burden of osteoarthritis throughout the whole body

ACR/ARHP Annual Meeting 2012: Understanding Pain Signals May Pave Path to More Effective Therapies

Susan Bernstein | February 1, 2013

The ability to differentiate the types of pain affiliated with rheumatic diseases can help rheumatologists better diagnose and treat patients

ACR/ARHP Annual Meeting 2012: Immunosuppressed Rheumatic Disease Patients Still Candidates for Vaccines

Thomas R. Collins | February 1, 2013

People with rheumatic diseases can be considered to receive flu and pneumococcal vaccines even if they’re on immunosuppressive drugs

ACR/ARHP Annual Meeting 2012: New Research Into Stem Cell Therapy and Drugs May Lead to Breakthrough Treatments for Osteoarthritis

Susan Bernstein | February 1, 2013

Novel strategies for treating osteoarthritis aim to relieve pain, rebuild or replenish deteriorated cartilage and bone, or to replace the joint through surgery

ACR/ARHP Annual Meeting 2012: Will Novel Strategies Lead to Breakthroughs in Treating Osteoarthritis?

Susan Bernstein | February 1, 2013

ACR/ARHP Annual Meeting 2012: Early Signs of Rheumatoid Arthritis May Appear Outside the Joints

Mary Beth Nierengarten | February 1, 2013

Evidence that suggests rheumatoid arthritis (RA) starts in mucosal sites such as the oral cavity and lung may lead to improved treatment and prevention of the disease